Literature DB >> 2842173

Introduction of macromolecules into mammalian cells by cell fusion.

T Uchida1.   

Abstract

Proteins with molecular weights of up to 500K can be enclosed in erythrocyte ghosts by exposing the ghosts to hypotonic solution containing these proteins. The proteins can then be introduced into recipient cells by fusing the ghosts with the cells using HVJ, PEG, or influenza virus. Some applications of this method are described. By an improved method, 15 kbp DNA and IgM (900 kDa) can be entrapped in erythrocyte membranes and these are then treated with liposomes containing gangliosides and HVJ. These treated membranes containing large macromolecules fuse with almost 100% of the recipient cells used. Naked liposomes infrequently fuse with cultured cells, so introduction of their contents into cells is very inefficient. However, liposomes constituted from lipid and glycoproteins (HN and F) of HVJ (Sendai virus), by removing a nonionic detergent, fuse with cells about 200 times more efficiently than naked liposomes. Naked liposomes can fuse with specific cells, such as cells infected with subacute sclerosing panencephalitis virus or with human immunodeficiency virus. Plasmid DNA and mRNA of up to about 40 kbp can be entrapped efficiently in liposomes associated with gangliosides formed by reverse-phase evaporation, and then reacted with HVJ. The contents of the resulting liposomes with HVJ can be introduced efficiently into cultured cells in a suspended or plated state, and nearly all the cells then express the gene transiently. This procedure is also effective for obtaining stable transformants of many kinds of cultured cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2842173     DOI: 10.1016/0014-4827(88)90372-2

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  4 in total

1.  Stable, resealable pores formed in sea urchin eggs by electric discharge (electroporation) permit substrate loading for assay of enzymes in vivo.

Authors:  R R Swezey; D Epel
Journal:  Cell Regul       Date:  1989-11

2.  Transforming growth factor-{beta}1 modulates responses of CD34+ cord blood cells to stromal cell-derived factor-1/CXCL12.

Authors:  Sunanda Basu; Hal E Broxmeyer
Journal:  Blood       Date:  2005-03-29       Impact factor: 22.113

Review 3.  Novel drug delivery systems for glaucoma.

Authors:  E Lavik; M H Kuehn; Y H Kwon
Journal:  Eye (Lond)       Date:  2011-04-08       Impact factor: 3.775

Review 4.  Promising therapeutic drug delivery systems for glaucoma: a comprehensive review.

Authors:  Rohan B Singh; Parul Ichhpujani; Sahil Thakur; Sumeet Jindal
Journal:  Ther Adv Ophthalmol       Date:  2020-03-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.